🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/01/2007 17,22 17,70 16,50 17,46 +1,39% 6,97% 81.233
22/01/2007 17,28 17,58 17,16 17,22 +0,00% 2,43% 102.150
19/01/2007 16,86 17,40 16,80 17,22 +1,06% 3,56% 72.850
18/01/2007 17,58 17,88 16,92 17,04 -3,07% 5,46% 127.683
17/01/2007 18,60 18,60 17,52 17,58 -5,48% 5,81% 227.000
16/01/2007 18,72 18,96 18,36 18,60 +0,00% 3,21% 146.933
12/01/2007 18,90 19,02 18,42 18,60 -0,96% 3,17% 69.167
11/01/2007 18,24 19,02 18,24 18,78 +2,96% 4,28% 101.683
10/01/2007 18,06 18,24 17,64 18,24 +2,01% 3,32% 97.367
09/01/2007 18,24 18,48 17,70 17,88 -1,97% 4,28% 187.617
08/01/2007 18,42 18,60 18,06 18,24 -1,62% 2,93% 74.600
05/01/2007 19,08 19,08 18,30 18,54 -3,44% 4,09% 123.117
04/01/2007 18,54 19,38 18,30 19,20 +3,56% 5,83% 243.050
03/01/2007 19,26 19,68 18,42 18,54 -2,83% 6,54% 89.050
29/12/2006 19,38 19,44 18,60 19,08 -1,55% 4,33% 156.967
28/12/2006 19,62 19,86 19,38 19,38 -2,42% 2,45% 96.433
27/12/2006 19,68 19,98 19,50 19,86 +0,61% 2,44% 61.200
26/12/2006 20,04 20,28 19,62 19,74 -2,08% 3,29% 75.400
22/12/2006 20,10 20,28 19,98 20,16 -0,30% 1,49% 50.383
21/12/2006 20,10 20,52 20,04 20,22 +0,00% 2,39% 49.817
20/12/2006 20,82 20,82 20,04 20,22 +0,90% 3,75% 75.350
19/12/2006 20,40 20,40 19,92 20,04 -2,91% 2,35% 80.833
18/12/2006 21,30 21,42 19,92 20,64 -2,55% 7,04% 159.033
15/12/2006 21,60 21,84 21,12 21,18 -1,94% 3,33% 93.550
14/12/2006 21,30 21,84 21,12 21,60 +1,98% 3,38% 71.450
13/12/2006 21,90 22,08 21,00 21,18 -3,29% 4,93% 100.950
12/12/2006 22,20 22,56 21,78 21,90 -1,62% 3,51% 93.867
11/12/2006 22,62 22,86 22,20 22,26 -0,80% 2,92% 146.200
08/12/2006 22,80 22,80 22,26 22,44 -2,35% 2,37% 67.550
07/12/2006 23,28 23,28 22,74 22,98 +0,00% 2,32% 77.967